Literature DB >> 7075570

Comparative bioavailability of phenytoin from generic formulations in the United Kingdom.

S S Chen, J Allen, J Oxley, A Richens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075570     DOI: 10.1111/j.1528-1157.1982.tb05062.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  8 in total

Review 1.  Is generic prescribing acceptable in epilepsy?

Authors:  F M Besag
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

Review 2.  Rational use of generic psychotropic drugs.

Authors:  Maren Carbon; Christoph U Correll
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

Review 3.  Therapeutic Basis of Generic Substitution of Antiseizure Medications.

Authors:  Sarah Elmer; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2022-03-03       Impact factor: 4.402

4.  Bioavailability and dissolution of proprietary and generic formulations of phenytoin.

Authors:  I Soryal; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

Review 5.  Prescribing antiepileptic drugs: should patients be switched on the basis of cost?

Authors:  Barbara C Jobst; Gregory L Holmes
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

Authors:  A Richens
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

7.  Three-way, three-period, crossover bioequivalence study of single oral dose of three brands of 300 mg phenytoin sodium tablets marketed in India, on healthy Indian human volunteers.

Authors:  Maulik S Doshi; Anuja A Naik; Mohit R Mehta; Nithya J Gogtay; Urmila M Thatte; Mala D Menon
Journal:  J Pharmacol Pharmacother       Date:  2013-10

Review 8.  Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature.

Authors:  Muhammad Atif; Muhammad Azeem; Muhammad Rehan Sarwar
Journal:  Springerplus       Date:  2016-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.